| (SEK) | Sep 2024 | Y/Y change |
|---|---|---|
| Revenue | 1.16M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ENZY.ST returned -20.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -2.6% |
| 1 year | -20.9% |
| 5 years | -81.0% |
| 10 years | -29.0% |
| All-time high | kr 28.24 (Mar 2013) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in ENZY.ST would be worth today ›No. Enzymatica AB (publ) has not paid a dividend in the past 12 months.
Enzymatica AB (publ) is part of the Healthcare sector.
Enzymatica AB (publ) has a market cap of 461.20M SEK, based on the latest quote.
